Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.83 HKD | +1.22% | 0.00% | -9.78% |
Apr. 30 | LH Group Limited Announces Board and Committee Changes | CI |
Apr. 29 | Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy | MT |
Sales 2022 | 1.07B 137M | Sales 2023 | 1.28B 164M | Capitalization | 736M 94.17M |
---|---|---|---|---|---|
Net income 2022 | 77M 9.85M | Net income 2023 | 88M 11.26M | EV / Sales 2022 | 0.69 x |
Net cash position 2022 | 118M 15.13M | Net Debt 2023 | 2.46M 315K | EV / Sales 2023 | 0.58 x |
P/E ratio 2022 |
11
x | P/E ratio 2023 |
8.36
x | Employees | 1,667 |
Yield 2022 |
7.26% | Yield 2023 |
9.58% | Free-Float | 25% |
1 day | +1.22% | ||
3 months | -7.78% | ||
6 months | -19.42% | ||
Current year | -9.78% |
Managers | Title | Age | Since |
---|---|---|---|
Kit Lung Wong
CEO | Chief Executive Officer | 50 | 17-06-19 |
Dong John Yang
DFI | Director of Finance/CFO | 49 | 23-04-10 |
Hiu Yi Chan
ADM | Chief Administrative Officer | 38 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wai Man Hung
BRD | Director/Board Member | 55 | 18-05-29 |
Kit Lung Wong
CEO | Chief Executive Officer | 50 | 17-06-19 |
Sau Chee Ko
BRD | Director/Board Member | 58 | 17-06-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 0.83 | +1.22% | 658 000 |
24-05-08 | 0.82 | 0.00% | 46,000 |
24-05-07 | 0.82 | -1.20% | 382,000 |
24-05-06 | 0.83 | 0.00% | 184,000 |
24-05-03 | 0.83 | 0.00% | 1,582,000 |
Delayed Quote Hong Kong S.E., May 09, 2024 at 02:38 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.78% | 83.92M | |
+35.42% | 11.06B | |
+13.38% | 8.38B | |
+34.04% | 2.58B | |
-1.38% | 2.13B | |
-15.46% | 1.97B | |
-2.97% | 1.73B | |
+6.40% | 1.69B | |
-2.10% | 1.44B | |
-13.80% | 940M |
- Stock Market
- Equities
- 1978 Stock